In our previous study, we found higher cytoglobin (Cygb) expression in keloid than normal tissue. Cytoglobin is a new globin family protein which function is still being studied to date. The purpose of this research is to elucidate the function of Cygb in human skin keloid fibroblasts (KFs), especially its role in intracellular reactive oxygen species (ROS) levels.
Introduction
Keloid, also known as keloid disorder and keloidal scar, is a benign tumor that can grow beyond the wound limit and has a high recurrence rate. (1) In the skin, keloids are typically raised, firm, red to pink, and sometimes itchy. (2) Keloid usually cause aesthetic problems so it can initiate psychological disorders in patients. ( 3) The exact cause of keloid to date is unknown. Presumably, there are abnormalities of wound healing process caused by an imbalance between the process of synthesis and collagen degradation. (2, 4) It has been reported that skin keloid fibroblasts (KFs) have stronger proliferating activity. (3) In keloids, there is also a state of hypoxia and an increase in reactive oxygen species (ROS) production characterized by increased hypoxia-inducible factor (HIF)-1α expression and higher intracellular ROS levels than normal tissue.(5-7) One of the regulated genes regulated by HIF-1α is cytoglobin (Cygb). (8) (9) (10) Currently, optimal treatment of keloid remains undefined (2), because there is still limited knowledge about factors that may play a role in keloid pathophysiology, include Cygb. Cygb is a new globin family protein which function is still widely studied to date. Cygb is found not only in the cytoplasm but also in the nucleus so it is thought to have a wider function than other globin proteins. (11) Our findings in previous studies found that Cygb gene expression was higher in keloid compared to normal tissue. (6) We suspect the high expression of Cygb is related to its ability to act as a ROS scavenger. (11) This study aims to elucidate the role of Cygb in human skin KFs.
Methods

Study Design
This research is an experimental in vitro research conducted on fibroblasts cell cultures taken from human skin keloid lesion. We collected keloid scar specimens from 3 patients treated at Budi Kemuliaan Hospital (Jakarta, Indonesia), who underwent a second subcutaneous operation and had keloids in their previous surgical wounds. All patients agreed to participate in this study after receiving the inform consent. A clinical and pathological investigation from all keloid cases were fully proven. Each sample was divided into 2 groups, the group treated with small interfering RNA (siRNA) (+) Cygb and untreated group (as control). All experiment was repeated 3 times.
The research was conducted in the laboratory of 
Cell Culture and Treatment
The primary skin KFs culture has been establishing, as noted previously. (12) We were grown the specimens in Dulbecco Modified Eagle Medium (DMEM) and amplified it in 10% Fetal Bovine Serum (FBS) (Gibco, New York, USA), 1% Penicillin/Streptomycin and 1% Fungizone (Gibco). All specimens were cultured with 5% CO 2 at 37 o C in a humidified incubator. For siRNA (+) Cygb group, skin KFs were treated with human siRNA (+) Cygb.
siRNA Transfection
The siRNA targeting Cygb (siRNA (+) Cygb) were purchased from Santacruz. During 24 hours, skin KFs cells grown to 50-60% confluence in antibiotic-free medium for in vitro transfection, and then transfected with siRNA (+) Cygb using siRNA Transfection Medium sc-36868 (Santacruz) at dose 20 pmol according to the manufacturer's protocol. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis performed to validate the efficiency of silencing.
Dichlorodihydrofluorescein Diacetate (DCFHDA) Intracellular levels of ROS were estimated by using the fluorescent dye 2',7'-Dichlorodihydrofluorescein diacetate (DCFHDA) (Invitrogen, California, USA). Cells which used as control and experimental were plated in a similar number. We were plated the skin KFs in 96-well plates at a density 1x10 4 cell/well, then for treatment group, we typically transfected it with siRNA (+) Cygb. Three days after transfection, the cells were incubated for 30 minutes with 10 μM of DCFHDA washed in phosphate-buffered saline (PBS). The absorbance of the cells in each group was monitored at an excitation of 490 nm and emission of 520 nm using a microplate reader (Nanodrop Thermo Scientific Varioscan Flash) (Thermo Fisher Scientific, Massachusetts, USA).
qRT-PCR
Total RNA was extracted from skin KFs using TriPure Isolation Reagent (Promega, Wisconsin, USA) according to the manufacturer's instructions. An amount of 50 ng of total RNA isolate per 10 µL of RT reaction was performed using LightCycler® 480 RT-PCR with SensiFAST SYBR NoROX Kit (Bioline, London, UK). The specific primers for Cygb were Forward 5'-CAGTTCAAGCACATGGAGGA -3'and Reverse 5'-GTGGGAAGTCACTGGCAAAT-3'; and for 18S RNA were Forward 5'-AAACGGCTACCACATCCAAG-3'and Reverse 5'-CCTCCAATGGATCCTCGTTA-3'. The 18S RNA was performed as an internal control. Then, the Livak formula was deliberated for relative quantification of the target gene. All reactions were performed in duplicates.
Statistical Analysis
Data are presented as the mean±SD of triplicate experiments. The independent T-test was employed for statistical analysis, with significant differences determined as p<0.05.
Results
To analyze the effect of Cygb in human skin KFs, we generated transfection of siRNA targeting Cygb. The qRT-PCR analysis indicated that the expression of Cygb was obviously decreased by siRNA (+) Cygb (Figure 1 ) compared to control. Furthermore, we examined the effect ** ** * of Cygb inhibition on human skin KFs intracellular ROS level. As shown in Figure 2 , treatment with siRNA (+) Cygb significantly increased the intracellular ROS level of human skin KFs. Figure 3 represents the correlation of Cygb mRNA and intracellular ROS levels in human skin KFs. The correlation between the Cygb mRNA and intracellular ROS levels is moderate negative correlation (Pearson, r=-0.651; p<0.05; n=27). This indicates that if the Cygb expression decreases then the ROS level will increase, or vice versa.
Discussion
There is a negative correlation between Cygb expression and intracellular ROS levels on human skin KFs. This observation is consistent with previous reports who showed that Cygb has a role as a ROS/reactive nitrogen species (RNS) scavenger. Similar to neuroglobin and cytochrome C, Cygb has a hexacoordinated structure and ability to detoxify radicals by reaction with their heme. (13) Based on previous in vitro studies, the ability of Cygb has been proved. The Cygb had a peroxidase activity and able to create a bond with various ligands (such as oxygen, nitric oxide and other free radicals). It indicates the important role of Cygb for scavenging the free radicals (i.e., reactive oxygen and nitrogen species) and modulating the cellular redox signaling than modulating the O 2 metabolism. (14, 15) In this study, we used siRNA to suppress Cygb because siRNA is one of the recent methods mediating RNA interference effect with high sensitivity and specificity. (16 
Conclusion
There is a negative correlation between Cygb expression and intracellular ROS levels, we suggest Cygb acts as a ROS scavenger in human skin KFs.
